Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

Tatjana Paunesku, Tianyi Ke, Rohan Dharmakumar, Nicole Mascheri, Aiguo Wu, Barry Lai, Stefan Vogt, Jörg Maser, Kenneth Thurn, Barbara Szolc-Kowalska, Andrew Larson, Raymond Bergan, Reed Omary, Debiao Li, Zheng Rong Lu, Gayle E. Woloschak

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Nanoconjugates composed of titanium dioxide (TiO2) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection of cultured cancer cells with these nanoconjugates showed them to be superior to the free contrast agent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently, T1-weighted contrast enhancements were observed in cells treated with nanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time, Gd accumulation, and intracellular delivery may find its use in Gd neutron-capture cancer therapy.

Original languageEnglish (US)
Pages (from-to)201-207
Number of pages7
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume4
Issue number3
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Nanoconjugates
Oligonucleotides
Gadolinium
Magnetic resonance
DNA
Magnetic Resonance Spectroscopy
Contrast Media
Neutron Capture Therapy
Cells
Nanoparticles
Titanium dioxide
Transfection
Cultured Cells
Neoplasms
Neutrons
Magnetic Resonance Imaging
Imaging techniques

Keywords

  • Magnetic resonance imaging
  • Nanoconjugates
  • Subcellular targeting

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Biotechnology
  • Biophysics
  • Medicine (miscellaneous)
  • Medicine(all)

Cite this

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. / Paunesku, Tatjana; Ke, Tianyi; Dharmakumar, Rohan; Mascheri, Nicole; Wu, Aiguo; Lai, Barry; Vogt, Stefan; Maser, Jörg; Thurn, Kenneth; Szolc-Kowalska, Barbara; Larson, Andrew; Bergan, Raymond; Omary, Reed; Li, Debiao; Lu, Zheng Rong; Woloschak, Gayle E.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 4, No. 3, 09.2008, p. 201-207.

Research output: Contribution to journalArticle

Paunesku, T, Ke, T, Dharmakumar, R, Mascheri, N, Wu, A, Lai, B, Vogt, S, Maser, J, Thurn, K, Szolc-Kowalska, B, Larson, A, Bergan, R, Omary, R, Li, D, Lu, ZR & Woloschak, GE 2008, 'Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 4, no. 3, pp. 201-207. https://doi.org/10.1016/j.nano.2008.04.004
Paunesku, Tatjana ; Ke, Tianyi ; Dharmakumar, Rohan ; Mascheri, Nicole ; Wu, Aiguo ; Lai, Barry ; Vogt, Stefan ; Maser, Jörg ; Thurn, Kenneth ; Szolc-Kowalska, Barbara ; Larson, Andrew ; Bergan, Raymond ; Omary, Reed ; Li, Debiao ; Lu, Zheng Rong ; Woloschak, Gayle E. / Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2008 ; Vol. 4, No. 3. pp. 201-207.
@article{0c931dafb8114579bdff27a4d93a6a01,
title = "Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images",
abstract = "Nanoconjugates composed of titanium dioxide (TiO2) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection of cultured cancer cells with these nanoconjugates showed them to be superior to the free contrast agent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently, T1-weighted contrast enhancements were observed in cells treated with nanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time, Gd accumulation, and intracellular delivery may find its use in Gd neutron-capture cancer therapy.",
keywords = "Magnetic resonance imaging, Nanoconjugates, Subcellular targeting",
author = "Tatjana Paunesku and Tianyi Ke and Rohan Dharmakumar and Nicole Mascheri and Aiguo Wu and Barry Lai and Stefan Vogt and J{\"o}rg Maser and Kenneth Thurn and Barbara Szolc-Kowalska and Andrew Larson and Raymond Bergan and Reed Omary and Debiao Li and Lu, {Zheng Rong} and Woloschak, {Gayle E.}",
year = "2008",
month = "9",
doi = "10.1016/j.nano.2008.04.004",
language = "English (US)",
volume = "4",
pages = "201--207",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

AU - Paunesku, Tatjana

AU - Ke, Tianyi

AU - Dharmakumar, Rohan

AU - Mascheri, Nicole

AU - Wu, Aiguo

AU - Lai, Barry

AU - Vogt, Stefan

AU - Maser, Jörg

AU - Thurn, Kenneth

AU - Szolc-Kowalska, Barbara

AU - Larson, Andrew

AU - Bergan, Raymond

AU - Omary, Reed

AU - Li, Debiao

AU - Lu, Zheng Rong

AU - Woloschak, Gayle E.

PY - 2008/9

Y1 - 2008/9

N2 - Nanoconjugates composed of titanium dioxide (TiO2) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection of cultured cancer cells with these nanoconjugates showed them to be superior to the free contrast agent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently, T1-weighted contrast enhancements were observed in cells treated with nanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time, Gd accumulation, and intracellular delivery may find its use in Gd neutron-capture cancer therapy.

AB - Nanoconjugates composed of titanium dioxide (TiO2) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection of cultured cancer cells with these nanoconjugates showed them to be superior to the free contrast agent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently, T1-weighted contrast enhancements were observed in cells treated with nanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time, Gd accumulation, and intracellular delivery may find its use in Gd neutron-capture cancer therapy.

KW - Magnetic resonance imaging

KW - Nanoconjugates

KW - Subcellular targeting

UR - http://www.scopus.com/inward/record.url?scp=49649116088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49649116088&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2008.04.004

DO - 10.1016/j.nano.2008.04.004

M3 - Article

C2 - 18567541

AN - SCOPUS:49649116088

VL - 4

SP - 201

EP - 207

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 3

ER -